Home / Conditions / Type 1 Diabetes (page 48)

Type 1 Diabetes

Type 1 Diabetes Treatment and Research: Type 1 diabetes is an autoimmune disorder that destroys pancreatic beta cells. Once called juvenile diabetes, Type 1 is diagnosed most often in children, but can be expressed in adults as well. Incidence is highest among non-hispanic whites, according to the NDEP. Adults with Type 1 make up 5% of all diagnosed diabetes patients.New tools, techniques, treatments, drugs and devices can help you improve outcomes for your patients with Type 1.

‘Smart’ Insulin Holds Promise for Type 1 Diabetes Patients

A novel insulin that automatically adjusts blood sugar may mitigate some of the complications associated with insulin dosing for patients with type 1 diabetes… Self-administered insulin is the most important therapeutic to provide control over blood glucose levels for patients with type 1 diabetes. However, standard insulin therapy introduces a …

Read More »

Breastfeeding May Lower Risk of Type 1 Diabetes

A recent study discovers that there may be an association between breastfeeding and lowering risk of type 1 diabetes… The objective of this study was to determine the association of breast feeding duration with the risk of type 1 diabetes in genetically predisposed newborns. In addition, this study looked at …

Read More »

Practical Diabetes Care, 3rd Ed., Excerpt #4: Type 1 Diabetes: Insulin Treatment Part 1 of 2

alt

David Levy, MD, FRCP Introduction Insulin treatment in type 1 diabetes is substitution/replacement hormone treatment, but replacement is much more variable and difficult to achieve than in other hormone deficiencies (e.g. thyroid, adrenal, gonadal hormones) because of the minute-by-minute variation in insulin secretion by the intact pancreas, which cannot yet be …

Read More »

Effects of GIP and GLP-1 on Glucagon Response in Type 1 Diabetes

Glucose-dependent insulinotropic polypeptide and glucagon- like peptide-1 have glucose-dependent effects on glucagon secretion but differ in their effects on type 1 and type 2 diabetes patients… From various studies we know that glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) have glucose-dependent effects on glucagon secretion. GIP causes increased glucagon …

Read More »

Study Finds Beta Cells Not Completely Lost in Type 1 Patients

Most with long-term diagnosis foud to continue to secrete low levels of insulin… In a large-population based study, researchers used sensitive C-peptide assays to demonstrate that 43-74% people with longstanding (>5 years) type 1 diabetes are microsecretors of endogenous insulin with C-peptide levels. The Scottish researchers measured the occurrence of …

Read More »